Sort by
Refine Your Search
-
Position Description The Condensed Matter Theory and Quantum Computing Group at the University of Basel led by Prof. Jelena Klinovaja and Prof. Daniel Loss invites applications for PhD positions
-
Building a quantum computer that can solve real-world problems will require the integration of many highly coherent qubits. Hole-spin qubits in planar germanium quantum wells are among the most
-
, including cutting edge quantum physics and chemistry, material science, nanotechnology, biochemistry, cell biology, or medical research. The SNI PhD programme includes multiple social events, trainings in
-
program by experimentally examining human behaviors of environmental relevance. To this end, it will make use of laboratory procedures (e.g., decision-making tasks, bicycle simulators) and consequential
-
One PhD scholarship (for 1 year) within the Department of Ancient Civilizations at the University of Basel The PhD program of the Department of Ancient Civilizations at the University of Basel
-
with partners at the hospitals, universities and institutes in Basel, we generate our own data, on the newest spatial and single-cell platforms. Your profile Required: ● MSc in computer
-
characterisation, and computational modelling to investigate the relationship between matrix properties and osteogenesis. This will contribute to deciphering the importance of mechanical stimulation of the cellular
-
Your position You will work on the development of a nanopore-based platform for single-molecule analysis of nanoclusters. Your research will include: • Establishing nanopore assays for detecting and characterizing individual nanoclusters • Engineering and purify protein nanopores with tailored...
-
internationally in our research and study programs. The PhD candidate will join the Human Development group at the Faculty of Psychology, University of Basel and contribute to a research program investigating the
-
translational research program that develops virus-specific T-cell therapies with clinical application through close collaboration with clinicians, GMP manufacturing facilities, and clinical trial units. It